This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Source: OpenUrlAbstract/FREE Full Text
Investigators at multiple international institutions conducted a longitudinal cohort study to characterize the clinical manifestations, complications, and treatments of patients with pyruvate kinase (PK) deficiency. Patients were eligible if they had biochemically or molecularly diagnosed PK deficiency. At the time of enrollment, data regarding participants’ PK genetic mutation (categorized as missense/missense [MM], missense/non-missense, and non-missense/non-missense [NN]), demographics, medical history (eg perinatal complications, transfusion history, history and timing of splenectomy), and laboratory studies were obtained retrospectively from medical records. The data were summarized using descriptive statistics. The investigators also used several tests of association to identify predictors of no response to splenectomy (defined as a hemoglobin <8 g/dL post-splenectomy).
Of 278 patients enrolled, 254 were included …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.